Funding for this research was provided by:
National Kidney Foundation
National Institute of Diabetes and Digestive and Kidney Diseases (DK106515-01)
Text and Data Mining valid from 2019-04-18
Received: 5 December 2018
Accepted: 2 April 2019
First Online: 18 April 2019
Ethics approval and consent to participate
: The Geisinger Institutional Review Board (IRB) approved the protocol (2017–0516), including the informed consent procedures which are as follows: Informed consent was obtained verbally for patients in the intervention arm to receive the home testing kit, which was not FDA-approved at the time of the research trial. Verbal consent was obtained as written consent would have required patients to come in person, limiting generalizability. Informed consent was waived for patients in the control arm as patients in the control received routine medical care. This study adheres to CONSORT guidelines (Supplemental Materials).
: Not applicable.
: J.C. is on the Scientific Advisory Board for Healthy.io.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.